Announced on its homepage: “Evonetix raises $30 million USD (£23 million GBP) PRESS RELEASE 02 March 2020 Evonetix raises $30 million USD (£23 million GBP) Series B...”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2024 – November 2025 · 4 captures · latest observed messagingTechnology to ignite the biology revolution
Spearheading a radical new approach to gene synthesis to improve access to high-quality, gene-length DNA. Redefine possible.
9 January 2024 · Technology to ignite the biology revolutionarchived page
3 January 2025 · Technology to ignite the biology revolutionarchived page
24 July 2025 · Technology to ignite the biology revolutionarchived page
10 November 2025 · Technology to ignite the biology revolutionarchived page
August 2022 – July 2023 · 2 capturesBringing semiconductor scale to a new generation of DNA synthesis
Bringing semiconductor scale to a new generation of DNA synthesis 3 Reimagine Biology Synthetic biology brings the power of nature to bear on the real challenges of today and the opportunities of tomo
17 August 2022 · Bringing semiconductor scale to a new generation of DNA synthesisarchived page
5 July 2023 · Bringing semiconductor scale to a new generation of DNA synthesisarchived page
March 2020 – July 2021 · 3 capturesReimagine biology
Reimagine biology 3 Reimagine biology 3 Our mission At Evonetix we are reimagining biology by developing a radically different approach to gene synthesis – a highly parallel desktop platform to synthe